CRO.Moscow: our medicine and clinical trials
The plasmide "Neovasculgene" is the first in group medicine for revascularisation for therapy of limb ischemia.
We initiated the III and IV phases of clinical trials and we will glad to enjoy you in our study as a co-laborator or investigatar.